364 related articles for article (PubMed ID: 33150035)
1. An Open-Label Prospective Study to Compare the Efficacy and Safety of Topical Fluticasone Versus Tacrolimus in the Proactive Treatment of Atopic Dermatitis.
Mudaliyar VR; Pathak A; Dixit A; Kumar SS
Dermatol Pract Concept; 2020 Oct; 10(4):e2020094. PubMed ID: 33150035
[TBL] [Abstract][Full Text] [Related]
2. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
3. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
4. Stratification of atopic dermatitis patients by patterns of response to proactive therapy with topical tacrolimus: low serum IgE levels and inadequately controlled disease activity at the start of treatment predict its failure.
Kasai H; Kawasaki H; Fukushima-Nomura A; Yasuda-Sekiguchi F; Amagai M; Ebihara T; Tanese K
Ann Med; 2021 Dec; 53(1):2205-2214. PubMed ID: 34797182
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics.
Hung SH; Lin YT; Chu CY; Lee CC; Liang TC; Yang YH; Wang LC; Chiang BL
Ann Allergy Asthma Immunol; 2007 Jan; 98(1):51-6. PubMed ID: 17225720
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials.
Schmitt J; von Kobyletzki L; Svensson A; Apfelbacher C
Br J Dermatol; 2011 Feb; 164(2):415-28. PubMed ID: 20819086
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of Topical Corticosteroids and Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis.
Pena J; Zameza PA; Pixley JN; Remitz A; Feldman SR
J Allergy Clin Immunol Pract; 2023 May; 11(5):1347-1359. PubMed ID: 36997119
[TBL] [Abstract][Full Text] [Related]
8. Fluticasone propionate 0.05% cream once daily versus clobetasone butyrate 0.05% cream twice daily in children with atopic dermatitis.
Wolkerstorfer A; Strobos MA; Glazenburg EJ; Mulder PG; Oranje AP
J Am Acad Dermatol; 1998 Aug; 39(2 Pt 1):226-31. PubMed ID: 9704834
[TBL] [Abstract][Full Text] [Related]
9. Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis.
Fröschl B; Arts D; Leopold C
GMS Health Technol Assess; 2007 Sep; 3():Doc09. PubMed ID: 21289943
[TBL] [Abstract][Full Text] [Related]
10. A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea.
Won CH; Seo PG; Park YM; Yang JM; Lee KH; Sung KJ; Park CW; Kim DW; Chang HS; Won YH; Kim KH
J Dermatolog Treat; 2004 Jan; 15(1):30-4. PubMed ID: 14754647
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment.
Doss N; Kamoun MR; Dubertret L; Cambazard F; Remitz A; Lahfa M; de Prost Y
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):321-9. PubMed ID: 19563466
[TBL] [Abstract][Full Text] [Related]
12. Therapy of atopic eczema.
Werfel T; Claes C; Kulp W; Greiner W; von der Schulenburg JM
GMS Health Technol Assess; 2006 Oct; 2():Doc19. PubMed ID: 21289970
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
Breuer K; Werfel T; Kapp A
Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
[TBL] [Abstract][Full Text] [Related]
16. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
[TBL] [Abstract][Full Text] [Related]
17. Intermittent or Sequential Topical Tacrolimus in Atopic Dermatitis: Systematic Review and Meta-Analysis.
Dhar S; De A; Saha A; Chitnis KR; Mane A; Dhoot D; Barkate H
Cureus; 2023 Dec; 15(12):e50640. PubMed ID: 38229798
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.
Frankel HC; Qureshi AA
Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and disease severity are correlated in children with atopic dermatitis.
Ben-Gashir MA; Seed PT; Hay RJ
Br J Dermatol; 2004 Feb; 150(2):284-90. PubMed ID: 14996099
[TBL] [Abstract][Full Text] [Related]
20. Addition of pimecrolimus cream 1% to a topical corticosteroid treatment regimen in paediatric patients with severe atopic dermatitis: a randomized, double-blind trial.
Meurer M; Eichenfield LF; Ho V; Potter PC; Werfel T; Hultsch T
J Dermatolog Treat; 2010 May; 21(3):157-66. PubMed ID: 20394491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
